GNH USA

Europe — EMA

Mycobutin (Rifabutin)

GNH USA supplies Mycobutin (Rifabutin), a Rifamycin antibiotic for Mycobacterium avium complex infection and tuberculosis. Request a quote for global supply.

Rifabutin

Request sourcing

1
Pack/s

What is Rifabutin?

Rifabutin, the active ingredient in Mycobutin, is a Rifamycin antibiotic presented as an oral tablet for oral use. It is employed in the treatment of infections caused by Mycobacterium avium complex and as part of multidrug regimens for tuberculosis in adult patients.

GNH USA supplies Mycobutin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides regulatory‑approved batches to qualified healthcare institutions across multiple regions.

What is Rifabutin used for?

Mycobutin (rifabutin) is indicated for specific mycobacterial infections within the antitubercular drug class.

- Mycobacterium avium complex (MAC) infection: reduces bacterial load and improves clinical outcomes in immunocompromised patients. - Tuberculosis (as part of combination therapy): contributes to bacterial eradication when used with other antitubercular agents.

What are the side effects of Rifabutin?

Rifabutin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Rash

Serious or Rare Side Effects: - Neutropenia or leukopenia - Hepatotoxicity - Uveitis or ocular inflammation

What precautions apply to Rifabutin?

When prescribing Mycobutin, clinicians should observe several safety considerations to minimize risk.

- Liver function monitoring: assess baseline hepatic enzymes and repeat during therapy. - Hematologic assessment: monitor complete blood count for neutropenia. - Drug interaction review: evaluate concurrent use of macrolides, protease inhibitors, and anticoagulants. - Renal impairment caution: adjust dose in patients with severe kidney dysfunction. - Hypersensitivity avoidance: discontinue if signs of allergic reaction appear. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

What does Rifabutin interact with?

Rifabutin interacts with several medications; awareness of the interaction level guides clinical management.

Major Interactions (Avoid): - Co‑administration with strong CYP3A4 inducers (e.g., rifampin, carbamazepine) markedly reduces rifabutin exposure. - Concurrent use with macrolide antibiotics (e.g., clarithromycin, azithromycin) can increase rifabutin levels and risk of toxicity.

Moderate Interactions (Monitor Closely): - Protease inhibitors (e.g., ritonavir) may elevate rifabutin concentrations; dose adjustment may be required. - Warfarin: rifabutin can enhance anticoagulant effect, necessitating INR monitoring. - Antiretroviral agents (e.g., efavirenz) may alter rifabutin metabolism, requiring therapeutic monitoring.

Frequently asked questions

What is Mycobutin used for?+
Mycobutin contains rifabutin and is used to treat infections caused by Mycobacterium avium complex (MAC) and to contribute to multidrug therapy for active tuberculosis. It is prescribed for adult patients when these specific mycobacterial infections have been confirmed, often in immunocompromised individuals or as part of a broader antitubercular regimen.
How does Rifabutin work?+
Rifabutin exerts its antibacterial effect by binding to the β‑subunit of the bacterial DNA‑dependent RNA polymerase enzyme. This binding blocks the initiation of RNA synthesis, halting transcription of essential genes and ultimately leading to bacterial cell death. Its activity is focused on mycobacterial species, including those responsible for MAC and tuberculosis.
What is the usual dose of Mycobutin?+
The specific dose of Mycobutin is determined by the prescribing clinician based on the patient’s condition, weight, renal and hepatic function, and any concomitant medications. Healthcare professionals follow established clinical guidelines and adjust the regimen as needed; patients should follow the prescriber’s instructions and not alter the dose on their own.
Is Mycobutin safe during pregnancy or breastfeeding?+
Safety data for rifabutin in pregnancy and lactation are limited, and the drug is generally classified as use‑only when the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their healthcare provider before starting Mycobutin.
How do I order Mycobutin from GNH USA?+
To request Mycobutin, visit the product page on gnh-usa.com and submit an enquiry with the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Mycobutin compare with other antitubercular drugs?+
Rifabutin belongs to the rifamycin class and shares a similar mechanism with rifampin but has a longer half‑life and different drug‑interaction profile. It is often preferred when patients experience rifampin‑related adverse effects or when co‑administration with certain macrolides is needed, as it may cause fewer hepatotoxic events in some cases.
How should Mycobutin be stored and handled?+
Mycobutin should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in areas with high humidity or extreme temperature fluctuations to maintain its stability.
How is Mycobutin administered?+
Mycobutin is administered orally, typically as a tablet taken with or without food, according to the prescriber’s directions. The exact timing relative to meals may be specified to optimize absorption or reduce gastrointestinal discomfort, and patients should swallow the tablet whole with an adequate amount of water.
What are the most serious risks associated with Mycobutin?+
The most serious risks include severe neutropenia or leukopenia, which can predispose to infections; hepatotoxicity that may progress to hepatitis; and ocular inflammation such as uveitis, which can threaten vision if not identified promptly. Patients should be monitored regularly for blood counts, liver function, and eye symptoms during therapy.
Who should not use Mycobutin?+
Mycobutin should be avoided in individuals with known hypersensitivity to rifabutin or any rifamycin‑class drug. Caution is also advised for patients with severe hepatic impairment, uncontrolled neutropenia, or those receiving contraindicated interacting medications without appropriate monitoring or dose adjustment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Rifabutin
Route
Oral Use
Manufacturer
Pfizer S.A.
Origin
EU

Related products

Mycobutin 150 mg/1

Mycobutin 150 mg/1

Rifabutin · 150 mg

Mycobutin
CAPSULE
Pfizer Laboratories Div Pfizer Inc
USA
Rifabutin 150 mg/1

Rifabutin 150 mg/1

Rifabutin · 150 mg

Rifabutin
CAPSULE
Marlex Pharmaceuticals, Inc.
USA
Mycobutin 150 mg

Mycobutin 150 mg

Rifabutin · 150 MG

Mycobutin
CAPSULE
PFIZER CANADA ULC
CANADA
Ansatipin

Ansatipin

Rifabutin

Pfizer Oy
EU